Intracranial hemorrhage associated with anticoagulation therapy

Area of Science:

• Neurology
• Neurosurgery
• Hematology

Background:

• Anticoagulation therapy is crucial for preventing thrombotic events but carries a risk of bleeding.
• Intracranial hemorrhage (ICH) is a serious complication of anticoagulation, necessitating careful risk assessment.
• Understanding the specific characteristics and risk factors for ICH in anticoagulated patients is vital for clinical management.

Observation:

• A series of nine patients experiencing intracranial hemorrhage during long-term anticoagulation therapy was reviewed.
• The study analyzed the relationship between ICH and other variables, including patient history and literature data.
• The subdural space was identified as the most frequent location for intracranial hemorrhage in this cohort.

Findings:

• No direct correlation was found between arterial hypertension and the occurrence of ICH in patients on anticoagulation.
• Prothrombin activity levels did not show a direct correlation with the incidence of intracranial hemorrhage.
• A favorable outcome was observed in six out of nine patients, with four of these patients having a subdural hematoma.

Implications:

• The findings suggest that while anticoagulation increases ICH risk, specific factors like hypertension and prothrombin levels may not be direct predictors.
• Subdural hematoma appears to be a common and potentially manageable form of ICH in anticoagulated individuals.
• Further research is warranted to elucidate precise risk factors and optimize management strategies for ICH in patients receiving long-term anticoagulation therapy.